Gilead Sciences | Acreedores Comerciales



Trade Creditors Cambio Fecha
AbbVie 2.94B 2.66B 2024-12
Agios Pharmaceuticals USD 17.53M 3.81M 2025-06
ALKERMES USD 99.21M 39.37M 2025-06
Alnylam Pharmaceuticals USD 102.39M 4.99M 2025-06
Amgen USD 18.03B 15.63B 2025-06
Biogen USD 408.4M 16.9M 2025-06
BioMarin Pharmaceutical 684.25M 390.5M 2025-06
Bristol-Myers Squibb USD 5.43B 1.42B 2025-06
Eli Lilly USD 4.08B 633.7M 2025-06
Gilead Sciences USD 582M 155M 2025-06
GlaxoSmithKline 14.82B 329M 2025-06
Glaxosmithkline 3.46B 10.01B 2024-12
Incyte USD 1.41B 1.21B 2025-06
J&J USD 9.54B 766M 2025-03
Merck USD 4.04B 261M 2025-06
Moderna USD 175M 51M 2025-06
Neurocrine Biosciences 104.6M 5.4M 2025-06
Novartis USD 4.51B 245M 2025-06
Pfizer USD 5.17B 74M 2025-06
PTC Therapeutics USD 206.31M 191.16M 2025-06
Regeneron Pharmaceuticals USD 723.9M 18.4M 2025-06
Sanofi 7.08B 14.54B 2025-06
Sarepta Therapeutics USD 136.7M 19.4M 2025-06
United Therapeutics 432M 426M 2025-06
Vertex Pharmaceuticals USD 3.71B 3.27B 2025-06


Gilead Sciences Acreedores Comerciales - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.